Skip to main content
. 2018 Feb 28;28(4):782–787. doi: 10.1097/IGC.0000000000001218

FIGURE 1.

FIGURE 1

Oncologic outcomes among the ART-DP, ART, and RH groups. No significant differences in progression-free and overall survival among the 3 groups were observed (P = 0.75 and P = 1.0, respectively).